Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | MET | P08581 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709352 | 0.94 | TNF (0.39) | TNFMEN1RAB9AKMT2AMAPK14 | |
| SCHEMBL30709495 | 0.91 | KMT2A (0.42) | MEN1RAB9AKMT2AMAPK14DUSP3 | |
| SCHEMBL22148706 | 0.87 | MAPT (0.33) | TNFMEN1KMT2ADYRK1AALOX5 | |
| SCHEMBL22148530 | 0.87 | TNF (0.33) | TNFMEN1KMT2AMAPK14DYRK1A | |
| SCHEMBL30709433 | 0.84 | TNF (0.35) | TNFMEN1KMT2AMAPK14DYRK1A | |
| SCHEMBL30709572 | 0.84 | MAPK14 (0.41) | RAB9AMAPK14DYRK1ADUSP3KCNH2 | |
| SCHEMBL30709414 | 0.84 | DYRK1A (0.41) | TNFMAPK14DYRK1ADUSP3KCNH2 | |
| SCHEMBL22148674 | 0.83 | MEN1 (0.36) | MEN1RAB9AKMT2ADUSP3 | |
| SCHEMBL30709398 | 0.83 | MEN1 (0.35) | MEN1RAB9AKMT2AMAPK14 | |
| SCHEMBL22148589 | 0.82 | ALDH1A1 (0.36) | MEN1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | TNF 3137/4885MEN1 2193/4885RAB9A 3239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.